Literature DB >> 25332262

Factors associated with spontaneous HBsAg clearance in chronic hepatitis B patients followed at a university hospital.

Sandro C Ferreira1, Silvana G F Chachá1, Fernanda F Souza1, Andreza C Teixeira1, Rodrigo C Santana2, Márcia G Villanova1, Sérgio Zucoloto3, Leandra N Ramalho4, Gleici S C Perdoná5, Afonso D C Passos5, Ana L C Martinelli1.   

Abstract

INTRODUCTION: Few studies have evaluated the factors involved in the spontaneous HBsAg seroclearance in patients with chronic hepatitis B (HBV) followed up on a long-term basis from areas with a low prevalence of HBV infection. We aimed to determine the rate of spontaneous HBsAg seroclearance and the factors related to it in patients with chronic HBV infection followed up at the Hepatitis Outpatient Clinic of HCFMRP from 1992-2008.
MATERIALS AND METHODS: A total of 548 patients with chronic HBV infection (366 with chronic hepatitis B and 182 inactive carriers) were followed for 15 years and 9 months with an annual measurement of HBV-DNA, ALT, AST and GGT (average of 4 annual determinations) and serology (HBsAg, HBeAg, Anti-HBeAg and Anti-HBsAg).
RESULTS: Spontaneous HBsAg seroclearance occurred in 40 patients (7.3%) with a mean age of 46.0 ± 14.4 years, corresponding to an annual rate of 0.7%.The factors related to spontaneous HBsAg seroclearance were inactive carrier status (67.5 vs. 32.5%, p = 0.000191) and age of more than 40 years (p = 0.0007). There was no difference in the rate of spontaneous HBsAg seroclearance when comparing males and females (p = 0.383). Patients with spontaneous HBsAg seroclearance did not progress to more severe forms of the disease during follow-up.
CONCLUSION: Spontaneous HBsAg seroclearance has a favorable long-term prognosis in patients with chronic HBV infection. HBsAg seroclearance occurred at rates compatible with low prevalence areas and was associated with low serum HBV-DNA levels and an age older than 40 years.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25332262

Source DB:  PubMed          Journal:  Ann Hepatol        ISSN: 1665-2681            Impact factor:   2.400


  11 in total

1.  Spontaneous loss of surface antigen among adults living with chronic hepatitis B virus infection: a systematic review and pooled meta-analyses.

Authors:  Kali Zhou; Caitlin Contag; Evans Whitaker; Norah Terrault
Journal:  Lancet Gastroenterol Hepatol       Date:  2019-01-22

2.  Study on the Retreatment, Outcome, and Potential Predictors of Recurrence in Patients With Recurrence of Hepatitis B After Functional Cure.

Authors:  Xiao Lin; Aixin Song; Junfeng Lu; Sujun Zheng; Zhongjie Hu; Lina Ma; Zhenhuan Cao; Hong Li; Yanhong Zheng; Shan Ren; Xinyue Chen
Journal:  Front Immunol       Date:  2022-07-04       Impact factor: 8.786

3.  Ethnic differences in incidence of hepatitis B surface antigen seroclearance in a real-life multicenter clinical cohort of 4737 patients with chronic hepatitis B infection.

Authors:  L H Nguyen; J Hoang; N H Nguyen; V D Vu; C Wang; H N Trinh; J Li; J Q Zhang; M H Nguyen
Journal:  Aliment Pharmacol Ther       Date:  2016-07-01       Impact factor: 8.171

Review 4.  Functional cure for chronic hepatitis B: accessibility, durability, and prognosis.

Authors:  Aixin Song; Xiao Lin; Xinyue Chen
Journal:  Virol J       Date:  2021-06-03       Impact factor: 4.099

5.  HBsAg may reappear following reactivation in individuals with spontaneous HBsAg seroclearance 8 years previously.

Authors:  Q Y Chen; X Y Wang; T J Harrison; X He; L P Hu; K W Li; H H Jia; Q L Yang; C Wang; Z L Fang
Journal:  Epidemiol Infect       Date:  2016-12-05       Impact factor: 4.434

6.  Identification of novel susceptibility loci associated with hepatitis B surface antigen seroclearance in chronic hepatitis B.

Authors:  Tae Hyung Kim; Eun-Ju Lee; Ji-Hye Choi; Sun Young Yim; Sunwon Lee; Jaewoo Kang; Yoo Ra Lee; Han Ah Lee; Hyuk Soon Choi; Eun Sun Kim; Bora Keum; Yeon Seok Seo; Hyung Joon Yim; Yoon Tae Jeen; Hoon Jai Chun; Hong Sik Lee; Chang Duck Kim; Hyun Goo Woo; Soon Ho Um
Journal:  PLoS One       Date:  2018-07-05       Impact factor: 3.240

7.  The Role of Promyelocytic Leukemia Protein in Steatosis-Associated Hepatic Tumors Related to Chronic Hepatitis B virus Infection.

Authors:  Yih-Lin Chung; Mei-Ling Wu
Journal:  Transl Oncol       Date:  2018-04-24       Impact factor: 4.243

8.  Durability of hepatitis B surface antigen seroclearance and subsequent risk for hepatocellular carcinoma: A meta-analysis.

Authors:  Aixin Song; Xiaoxiao Wang; Junfeng Lu; Yi Jin; Lina Ma; Zhongjie Hu; Yanhong Zheng; Chengli Shen; Xinyue Chen
Journal:  J Viral Hepat       Date:  2021-02-08       Impact factor: 3.728

9.  Time to seroconversion of HBsAg to anti-HBs in individuals who lost HBsAg during follow-up.

Authors:  M R H Roushan; M Mohammadpour; M Baiany; S Soleimani; A Bijani
Journal:  Epidemiol Infect       Date:  2016-06-08       Impact factor: 4.434

10.  Single-nucleotide polymorphism of rs7944135 (macrophage-expressed gene 1) is associated with hepatitis B surface antigen seroclearance in chronic hepatitis B infection: A cohort study.

Authors:  Lalu Muhammad Irham; Henry Sung-Ching Wong; Dyah Aryani Perwitasari; Wan-Hsuan Chou; Hwai-I Yang; Wei-Chiao Chang
Journal:  Medicine (Baltimore)       Date:  2019-12       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.